These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7876405)

  • 1. Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat.
    Hussain Y; Güzelhan C; Odink J; van der Beek EJ; Hartmann D
    J Clin Pharmacol; 1994 Nov; 34(11):1121-5. PubMed ID: 7876405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on dietary fat absorption of orlistat, administered at different times relative to meal intake.
    Hartmann D; Hussain Y; Güzelhan C; Odink J
    Br J Clin Pharmacol; 1993 Sep; 36(3):266-70. PubMed ID: 9114915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers.
    Melia AT; Zhi J; Zelasko R; Hartmann D; Güzelhan C; Guerciolini R; Odink J
    Eur J Clin Pharmacol; 1998; 54(9-10):773-7. PubMed ID: 9923583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary composition on the inhibition of fat absorption by orlistat.
    Güzelhan C; Odink J; Niestijl Jansen-Zuidema JJ; Hartmann D
    J Int Med Res; 1994; 22(5):255-65. PubMed ID: 7867870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.
    Bryson A; de la Motte S; Dunk C
    Br J Clin Pharmacol; 2009 Mar; 67(3):309-15. PubMed ID: 19220279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers.
    Zhi J; Melia AT; Guerciolini R; Chung J; Kinberg J; Hauptman JB; Patel IH
    Clin Pharmacol Ther; 1994 Jul; 56(1):82-5. PubMed ID: 8033498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.
    Di Marco M; Marier JF; Ducharme MP; Morin I; Engel C; Gulbranson S; Thudi NR; Murpani D; Rampal A; Monif T; Koundinya TS; Deo K; Monif T
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):319-26. PubMed ID: 18541129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
    Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
    Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects.
    O'Donovan D; Feinle-Bisset C; Wishart J; Horowitz M
    Br J Nutr; 2003 Nov; 90(5):849-52. PubMed ID: 14667178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects.
    Ahnen DJ; Guerciolini R; Hauptman J; Blotner S; Woods CJ; Wargovich MJ
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1291-9. PubMed ID: 17920338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal.
    Goedecke JH; Barsdorf M; Beglinger C; Levitt NS; Lambert EV
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1479-85. PubMed ID: 14634678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of fecal fat excretion induced by orlistat and chitosan.
    Guerciolini R; Radu-Radulescu L; Boldrin M; Dallas J; Moore R
    Obes Res; 2001 Jun; 9(6):364-7. PubMed ID: 11399783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipase inhibition and hormonal status, body composition and gastrointestinal processing of a liquid high-fat mixed meal in moderately obese subjects.
    Drent ML; Popp-Snijders C; Adèr HJ; Jansen JB; van der Veen EA
    Obes Res; 1995 Nov; 3(6):573-81. PubMed ID: 8653534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers.
    Melia AT; Zhi J; Koss-Twardy SG; Min BH; Smith BL; Freundlich NL; Arora S; Passe SM
    J Clin Pharmacol; 1995 Aug; 35(8):840-3. PubMed ID: 8522642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers.
    Carrière F; Renou C; Ransac S; Lopez V; De Caro J; Ferrato F; De Caro A; Fleury A; Sanwald-Ducray P; Lengsfeld H; Beglinger C; Hadvary P; Verger R; Laugier R
    Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G16-28. PubMed ID: 11408251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor.
    Borovicka J; Schwizer W; Guttmann G; Hartmann D; Kosinski M; Wastiel C; Bischof-Delaloye A; Fried M
    Gut; 2000 Jun; 46(6):774-81. PubMed ID: 10807887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of short-term (21-day) orlistat treatment on the physiologic balance of six selected macrominerals and microminerals in obese adolescents.
    Zhi J; Moore R; Kanitra L
    J Am Coll Nutr; 2003 Oct; 22(5):357-62. PubMed ID: 14559927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers.
    Zhi J; Melia AT; Koss-Twardy SG; Arora S; Patel IH
    J Clin Pharmacol; 1996 Feb; 36(2):152-9. PubMed ID: 8852391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers.
    Zhi J; Melia AT; Eggers H; Joly R; Patel IH
    J Clin Pharmacol; 1995 Nov; 35(11):1103-8. PubMed ID: 8626884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
    Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
    Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.